STOCK TITAN

Scienjoy Holding Corporation (SJ) Financials

SJ
FY2025 annual
Revenue $177.5M -4.9% YoY
Net Income -$84.0M -1643.8% YoY
EPS (Diluted) -$2.01 -1646.2% YoY
Free Cash Flow $10.0M +7.4% YoY
Market Cap $35.1M as of Oct 3, 2026
Price / Sales 0.2x on $177.5M revenue, FY2025
Price / Earnings n/m net loss, so no earnings multiple, FY2025
Price / Book 0.4x on $88.0M equity, Q4 FY2025

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 3, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period FY2025, ended Dec 31, 2025 Reported Currency USD FYE December

Newest figures come from the 20-F for FY2025, filed Apr 23, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the SJ SEC filings page.

Scienjoy Holding Corporation (SJ) reported $177.5M in revenue for fiscal year 2025, down 4.9% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 8 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI SJ FY2025

Scienjoy’s shrinking revenue masks a sharper shift: 2025 remained cash-generative while operating costs and accounting charges overwhelmed reported profit.

FY2024’s net income of $5.4M broadly tracked its operating cash flow of $9.4M. FY2025 then produced operating cash flow of $10.1M alongside a net loss of $84.0M, separating cash generation from reported earnings and indicating a major accounting or non-operating drag.

Revenue contracted again in FY2025, yet gross margin stayed near 18.0%; the damage appeared below gross profit as operating margin moved to -6.4%. That pattern points to expense pressure or other operating costs, not deterioration in the reported gross spread.

The balance sheet became materially smaller while liabilities also declined, so the deterioration was absorbed mainly through the equity base rather than heavier borrowing. A current ratio of 3.6x indicates reported short-term assets remained well above current obligations despite that contraction.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 44 / 100
Financial Health Score 44/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Scienjoy Holding Corporation's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
23

Scienjoy Holding Corporation has an operating margin of -6.3%, meaning the company loses $6 on every $100 of revenue. This results in a profitability score of 23/100. This is down from 3.0% the prior year.

Growth
12

Scienjoy Holding Corporation's revenue declined 4.9% year-over-year, from $186.8M to $177.5M. This contraction results in a growth score of 12/100.

Leverage
75

Scienjoy Holding Corporation carries a low D/E ratio of 0.19, meaning only $0.19 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 75/100, indicating a strong balance sheet with room for future borrowing.

Liquidity
85

With a current ratio of 3.60, Scienjoy Holding Corporation holds $3.60 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 85/100.

Cash Flow
48

Scienjoy Holding Corporation has a free cash flow margin of 5.6%, earning a moderate score of 48/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns
20

Scienjoy Holding Corporation posts a -95.4% return on equity (ROE), meaning it loses $95 for every $100 of shareholders' equity. This results in a returns score of 20/100. This is down from 3.3% the prior year.

Altman Z-Score Safe
3.29

Scienjoy Holding Corporation scores 3.29, well above the 2.99 safe threshold. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
5/7

Scienjoy Holding Corporation passes 5 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 2 of 4 profitability signals pass, all 1 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Mixed
N/A

Scienjoy Holding Corporation reported a net loss of $84.0M while generating $10.1M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.

Key Financial Metrics

Export CSV

Earnings & Revenue

None of these metrics is reported for Q4 2025.

Cash & Balance Sheet

Cash & Debt
$44.0M
YoY+27.2%
QoQ+5.6%
5Y CAGR+283.6%

Scienjoy Holding Corporation held $44.0M in cash as of Q4 2025; long-term debt is not reported for that period.

Free Cash Flow

Not reported for Q4 2025.

Dividends Per Share

Not reported for Q4 2025.

Shares Outstanding

Not reported for Q4 2025.

Margins & Returns

None of these metrics is reported for Q4 2025.

Capital Allocation

None of these metrics is reported for Q4 2025.

SJ Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SJ quarterly income statement
MetricQ4'2520-FQ2'256-KQ4'2410-KQ2'2410-QQ4'2310-KQ2'2310-QQ1'2310-QQ4'2210-K
RevenueN/AN/AN/AN/AN/A$50.1M-33.8%$44.3M-39.4%N/A
Cost of RevenueN/AN/AN/AN/AN/A$43.1M-30.1%$38.5M-30.1%N/A
Gross ProfitN/AN/AN/AN/AN/A$7.0M-50.0%$5.8M-67.7%N/A
R&D ExpensesN/AN/AN/AN/AN/A$2.5M-8.5%$2.4M-7.7%N/A
SG&A ExpensesN/AN/AN/AN/AN/A$2.6M+14.8%$2.5M-16.4%N/A
Operating IncomeN/AN/AN/AN/AN/A$1.6M-80.9%$715K-94.2%N/A
Interest ExpenseN/AN/AN/AN/AN/A$7K$5KN/A
Income TaxN/AN/AN/AN/AN/A-$900K-650.0%$858K-2.3%N/A
Net IncomeN/AN/AN/AN/AN/A$11.7M+16.2%-$458K-103.5%N/A
EPS (Basic)N/AN/AN/AN/AN/A$0.29-$0.01-102.7%$0.02
EPS (Diluted)N/AN/AN/AN/AN/A$0.29-$0.01-102.7%$0.02
Diluted Shares (Avg)N/AN/AN/AN/AN/A41M+5.6%40M+13.6%N/A

Not reported in any period shown, so not listed: EBITDA.

SJ Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SJ quarterly balance sheet
MetricQ4'2520-FQ2'256-KQ4'2410-KQ2'2410-QQ4'2310-KQ2'2310-QQ1'2310-QQ4'2210-K
Total Assets$101.6M-47.2%$199.9M+3.3%$192.5M-5.6%$193.4M-6.9%$204.0M-6.3%$207.7M-5.4%$207.9M-1.8%$217.8M+27.4%
Current Assets$54.8M-26.6%$77.7M+6.5%$74.6M-8.2%$73.0M-19.6%$81.3M-13.6%$90.9M-10.4%$83.6M-3.4%$94.1M-8.1%
Cash & Equivalents$44.0M+27.2%$41.7M+60.4%$34.6M+19.6%$26.0M-7.1%$28.9M+13.9%$28.0M+6.8%$26.2M-19.2%$25.4M-32.8%
Short-Term Investments$1.2M-76.3%$913K-81.2%$5.2M+16.1%$4.9M-66.7%$4.4M-24.5%$14.6M+146.2%$6.1M-0.9%$5.9M-3.4%
Accounts Receivable$6.2M-80.0%$31.1M-8.5%$31.0M-15.7%$34.0M-3.5%$36.8M-19.9%$35.2M-37.7%$34.9M-0.6%$45.9M+41.8%
Long-Term Investments$38.8M+5.4%$36.6M-0.6%$36.8M+2.7%$36.8M+13.8%$35.8M+8.6%$32.4M+22.2%$34.6M+23.9%$33.0M+123.6%
GoodwillN/A$25.6M+1.8%$25.0M-2.6%$25.1M+5.4%$25.7M+2.6%$23.8M-7.6%$25.2M-7.7%$25.1M+73.4%
Total Liabilities$16.7M-44.5%$32.1M+8.5%$30.1M-28.4%$29.6M-16.4%$42.1M-14.5%$35.4M-33.1%$39.1M-16.5%$49.2M+12.1%
Current Liabilities$15.2M-30.8%$22.4M+6.2%$22.0M-33.2%$21.0M-18.4%$33.0M-14.4%$25.8M-38.2%$28.8M-16.6%$38.5M+10.9%
Non-Current Liabilities$1.5M-81.6%$9.7M+14.2%$8.1M-11.0%$8.5M-11.0%$9.1M-15.2%$9.6M-14.5%$10.3M-16.2%$10.7M+16.4%
Long-Term DebtN/AN/AN/A$411K$2.3M+4.9%N/AN/A$2.2M+73.3%
Total Equity$88.0M-46.4%$170.2M+3.3%$164.3M+1.4%$164.8M-4.4%$162.1M-3.7%$172.4M+3.4%$168.8M+2.4%$168.3M+32.5%
Retained Earnings$13.2M-85.5%$94.3M+2.7%$90.8M+2.5%$91.8M-10.4%$88.6M-8.2%$102.5M+9.6%$96.4M+9.5%$96.4M+28.2%

Not reported in any period shown, so not listed: Inventory.

SJ Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SJ quarterly cash flow statement
MetricQ4'2520-FQ2'256-KQ4'2410-KQ2'2410-QQ4'2310-KQ2'2310-QQ1'2310-QQ4'2210-K
Stock-Based CompensationN/AN/AN/AN/AN/A-$927K-$276K+53.1%N/A

Not reported in any period shown, so not listed: Operating Cash Flow, Depreciation & Amortization, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Financing Cash Flow, Dividends Paid, Share Buybacks.

SJ Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SJ quarterly financial ratios
MetricQ4'2520-FQ2'256-KQ4'2410-KQ2'2410-QQ4'2310-KQ2'2310-QQ1'2310-QQ4'2210-K
Gross MarginN/AN/AN/AN/AN/A13.9%-4.5pp13.2%-11.5ppN/A
Operating MarginN/AN/AN/AN/AN/A3.2%-7.8pp1.6%-15.3ppN/A
Net MarginN/AN/AN/AN/AN/A23.3%+10.0pp-1.0%-19.0ppN/A
Return on EquityN/AN/AN/AN/AN/A6.8%+0.8pp-0.3%-8.2ppN/A
Return on AssetsN/AN/AN/AN/AN/A5.6%+1.1pp-0.2%-6.4ppN/A
Current Ratio3.60+0.2x3.480.0x3.39+0.9x3.47-0.1x2.460.0x3.52+1.1x2.90+0.4x2.44-0.5x
Debt-to-Equity0.190.0x0.19+0.2x0.18+0.2x0.00-0.2x0.010.0x0.20-0.1x0.23-0.1x0.010.0x
Asset TurnoverN/AN/AN/AN/AN/A0.24-0.1x0.21-0.1xN/A

Not reported in any period shown, so not listed: FCF Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Scienjoy Holding Corporation SJ FY2025 $177.5M -$84.0M -47.3% $35.1M 44/100
comScore, Inc. SCOR FY2025 $357.5M -$10.0M -2.8% $64.4M 33/100
Zedge, Inc. ZDGE FY2025 $29.4M -$2.4M -8.1% $47.1M 35/100
Giftify, Inc. GIFT FY2025 $83.2M -$10.5M -12.6% $19.5M 31/100
The Beachbody Company, Inc. BODI FY2025 $251.7M -$2.9M -1.1% $35.8M 31/100
Viewbix Inc. VBIX FY2025 N/A -$19.3M N/A $40.4M —

Frequently Asked Questions

What is Scienjoy Holding Corporation's annual revenue?

Scienjoy Holding Corporation (SJ) reported $177.5M in total revenue for fiscal year 2025. This represents a -4.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Scienjoy Holding Corporation's revenue growing?

Scienjoy Holding Corporation (SJ) revenue declined by 4.9% year-over-year, from $186.8M to $177.5M in fiscal year 2025.

Is Scienjoy Holding Corporation profitable?

No, Scienjoy Holding Corporation (SJ) reported a net income of -$84.0M in fiscal year 2025, with a net profit margin of -47.3%.

Scienjoy Holding Corporation (SJ) reported diluted earnings per share of -$2.01 for fiscal year 2025. This represents a -1646.2% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Scienjoy Holding Corporation (SJ) had EBITDA of -$10.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

Scienjoy Holding Corporation (SJ) had a gross margin of 18.3% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Scienjoy Holding Corporation (SJ) had an operating margin of -6.3% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Scienjoy Holding Corporation (SJ) had a net profit margin of -47.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Scienjoy Holding Corporation (SJ) has a return on equity of -95.4% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Scienjoy Holding Corporation (SJ) generated $10.0M in free cash flow during fiscal year 2025. This represents a 7.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Scienjoy Holding Corporation (SJ) generated $10.1M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Scienjoy Holding Corporation (SJ) had $101.6M in total assets as of fiscal year 2025, including both current and long-term assets.

Scienjoy Holding Corporation (SJ) invested $120K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Scienjoy Holding Corporation (SJ) invested $11.9M in research and development during fiscal year 2025.

Scienjoy Holding Corporation (SJ) had a current ratio of 3.60 as of fiscal year 2025, which is generally considered healthy.

Scienjoy Holding Corporation (SJ) had a debt-to-equity ratio of 0.19 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Scienjoy Holding Corporation (SJ) had a return on assets of -82.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Scienjoy Holding Corporation (SJ) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2025). The market capitalization is $35.1M as of Oct 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Scienjoy Holding Corporation (SJ) trades at 0.2x sales, its market capitalization divided by revenue of $177.5M revenue, FY2025. The market capitalization is $35.1M as of Oct 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Scienjoy Holding Corporation (SJ) has an Altman Z-Score of 3.29, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Scienjoy Holding Corporation (SJ) has a Piotroski F-Score of 5 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Scienjoy Holding Corporation (SJ) reported a net loss of $84.0M while generating $10.1M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Scienjoy Holding Corporation (SJ) scores 44 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top